Statement Of Cash Flows [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166254

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables
2,261 EUR
2,068 EUR
Adjustments for increase (decrease) in trade and other payables
468,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
196,000 EUR
137,000 EUR
Adjustments for gain (loss) on disposals, property, plant and equipment
16,000 EUR
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
130,000 EUR
191,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.